An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancer - Concepedia

Concepedia

Publication | Open Access

An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancer

DOI Full Paper Access

22

Citations

31

References

2012

Year

Fátima Cardoso, Jean‐Luc Canon, Dino Amadori, D. Aldrighetti, Jean-Pascal Machiels, Yasmina Bouko, Lev Verkh, Tiziana Usari, Kenneth A. Kern, C. Giorgetti,

References

	Year	Citations

Page 1